A comparative study of cellular and molecular pharmacology of doxorubicin and MEN 10755, a disaccharide analogue11Abbreviations: DOX, doxorubicin; DNA-SSB, single-strand breaks; and DNA-DSB, double-strand breaks.
- 22 May 2001
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 62 (1) , 63-70
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude miceEuropean Journal of Cancer, 2001
- Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharidesBiochemical Pharmacology, 1999
- Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzymeBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Cell death induced by topoisomerase-targeted drugs: more questions than answersBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Doxorubicin Disaccharide Analogue: Apoptosis-Related Improvement of Efficacy In VivoJNCI: Journal of the National Cancer Institute, 1997
- A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisonsTrends in Pharmacological Sciences, 1997
- DNA topoisomerase II from mammalian mitochondria is inhibited by the antitumor drugs, m-AMSA and VM-26Biochemical and Biophysical Research Communications, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicinNucleic Acids Research, 1990
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984